Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin (TECH, CEPH, ILMN, TLCR)

Below are the top mid-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin.

The trailing-twelve-month operating margin at Techne Corporation (NASDAQ: TECH) is 57.32%. TECH's ROE for the same period is 21.58%.

The trailing-twelve-month operating margin at Cephalon Inc (NASDAQ: CEPH) is 30.61%. CEPH's revenue for the same period is $2.81 billion.

The trailing-twelve-month operating margin at Illumina Inc (NASDAQ: ILMN) is 22.91%. ILMN's ROE for the same period is 12.11%.

The trailing-twelve-month operating margin at Talecris Biotherapeutics Holdings Corp (NASDAQ: TLCR) is 21.31%. TLCR's ROE for the same period is 40.27%.

Trading Ideas.